Almohanad Alkayyal PhD

Dr. Almohanad possess expertise in translational research, specifically, biologics development for cancer immunotherapy with extensive experience in animal modeling to study and evaluate preclinical efficacy as well as immunological responses to novel anticancer agents. He has gained extensive experience in oncolytic virus engineering as well as viral-host interactions.Has a great knowledge in the understating of the conduction/design of the clinical trials as well as the pre-clinical and the non-clinical evaluation of potential drug(s). My research program focuses on development of next- generation oncolytic cancer vaccines to effectively treat cancers.